Reversible Cerebral Vasoconstruction Syndromes
Arch Neurol 68:1005-1012,976, Singhal, A.B.,et al, 2011
Calcium Antagonists for Ischemic Stroke
Stroke 32:570-576, Horn,J. &Limburg,M., 2001
A Randomized Clinical Study of a Calcium-Entry Blocker (Lidoflzaine) in the Treatment of Comatose Survivors of Cardiac Arrest
NEJM 324:1225-1231, 1278-12801991., , 1991
Nimodipine after Resuscitation from Out-of-Hospital Ventricular Fibrillation
JAMA 264:3171-3177, Roine,R.O.,et al, 1990
Diagnosis and Management of Cerebral Venous Thrombosis:A Scientific Statement From the American Heart Association
Stroke 55:e77-e90, Saposnik,G.,et al, 2024
Contemporary Reversal of Oral Anticoagulation in Intracerebral Hemorrhage
Stroke 50:529-536, Bower, M.M.,et al, 2019
Outcome of Intracerebral Hemorrhage Associated with Different Oral Anticoagulants
Neurol 88:1693-1700,1686, Wilson, D.,et al, 2017
Early Clinical and Radiological Course, Management, and Outcome of Intracerebral Hemorrhage Related to New Oral Anticoagulants
JAMA Neurol 73:169-177,155, Purrucker, J.C.,et al, 2016
Comparison of the Efficacy and Safety of New Oral Anticoagulants with Warfarin in Patients with Atrial Fibrillation: A Meta-Analysis of Randomised Trials
Lancet 383:955-962,931, Ruff, C.T.,et al, 2014
Recurrence of ICH after Resumption of Anticoagulation with VK Antagonists
Neurol 82:1020-1026,1016, Poli, D.,et al, 2014
Factor Xa Inhibitors vs Warfarin for Preventing Stroke and Thromboembolism in Patients with Atrial Fibrillation
JAMA 311:1150-1151, Bruins Slot, K.M.H. & Berge, E., 2014
Intracranial Hemorrhage Mortality in Atrial Fibrillation Patients Treated with Dabigatran or Warfarin
Stroke 45:2286-2291, Alonso, A.,et al, 2014
Association of Cerebral Microbleeds with Mortality in Stroke Patients Having Atrial Fibrillation
Neurol 83:1308-1315,1304, Song, T.J.,et al, 2014
Closure of Patent Foramen Ovale versus Medical Therapy after Cryptogenic Stroke
NEJM 368:1092-1100,1152, Carroll, J.D.,et al, 2013
Percutaneous Closure of Patent Foramen Ovale in Cryptogenic Embolism
NEJM 368:1083-1091,1152, Meier, B.,et al, 2013
Paediatric Autoimmune Encephalopathies: Clinical Features, Laboratory Investigations and Outcomes in Patients with or without Antibodies to known Central Nervous System Autoantigens
JNNP 84:748-755, Hacohen, Y.,et al, 2013
Critique of Apixaban Versus Warfarin in Patients with Atrial Fibrillation
Stroke 43:922-923, Nedeltchev,K, 2012
Progressive Encephalomyelitis with Rigidity and Myoclonus Gycine and NMDA Receptor Antibodies
Neurol 77:439-443,414, Turner, M.R.,et al, 2011
Apixaban versus Warfarin in Patients with Atrial Fibrillation
NEJM 365:981-992,1052, Granger, C.B.,et al, 2011
Diagnosis and Management of the Antiphospholipid Syndrome
BMJ 340:1125-1132, Cohen,D., et al, 2010
Effect of Home Testing of International Normalized Ratio on Clinical Events
NEJM 363:1608-1620, Matchar,D.B.,et al, 2010
Study Design of the CLOSURE I Trial: A Prospective, Multicenter, Randomized, Controlled Trial to Evaluate the Safety and Efficacy of the STARFlex Septal Closure System Versus Best Medical Therapy in Patients With Stroke or TIA Due to Presumed Paradoxical Embolism Through a PFO
Stroke 41:2872-2883, Furlan,A.J.,et al, 2010
Long-Term Effects of the Concomitant Use of Memantine with Cholinesterase Inhibition in Alzheimer Disease
JNNP 80:600-607, Lopez,O.L.,et al, 2009
Warfarin-associated intraventricular hemorrhage
Neurol Res 29: 661-663, Zubkov, A.,et al, 2007
Intracerebral Hemorrhage Associated with Oral Anticoagulant Therapy
Stroke 37:256-262, Steiner, T.,et al, 2006
Survival after Treatment of Rabies with Induction of Coma
NEJM 352:2508-2514,2549, Willoughby,Jr.,R.E.,et al, 2005
Intracerebral Hemorrhage
The Neurologist 11:311-324, Badjatia,N. &Rosand,J., 2005
A Risk Score for Predicting Stroke or Death in Individuals with New-Onset Atrial Fibrillation in the Community
JAMA 290:1049-1056,1093, Wang,T.J.,et al, 2003
Stroke Prevention in Atrial Fibrillation
JAMA 290:1093-1095, Waldo,A.L., 2003
Effect of Intensity of Oral Anticoagulation on Stroke Severity and Mortality in Atrial Fibrillation
NEJM 349:1019-1026, Hylek,E.M.,et al, 2003
A Comparison of Warfarin and Aspirin for the Prevention of Recurrent Ischemic Stroke
NEJM 345:1444-1451,1493, Mohr,J.P.,et al, 2001
Oral Anticoagulation for Cerebral Ischemic of Arterial Origin
Neurol 57:1993-1999, Torn,M.,et al, 2001
Stroke in Patients with Heart Failure and Reduced Left Ventricular Ejection Fraction
Neurol 54:288-294, Pullicini,P.M.,et al, 2000
Clinicopath Conf
Cerebral Amyloid Angiopathy, Case 22-1996, NEJM 335:189-196996., , 1996
Oral Anticoagulants and Intracranial Hemorrhage, Facts and Hypotheses
Srroke 26:1471-1477, Hart,R.G.,et al, 1995
Risk Factors for Intracranial Hemorrhage in Outpatients Taking Warfarin
Ann Int Med 120:897-902, Hylek,E.M.&Singer,D.E., 1994
The Effect of Warfarin on Mortality and Reinfarction after Myocardial Infarction
NEJM 323:148-152, Smith,P.,et al, 1990
Etiology and Mortality of Status Epilepticus in Children, A Recent Update
Arch Neurol 46:74-76, Phillips,S.A.&Shanahan,R.J., 1989
The Dandy-Walker Syndrome
In Handbk of Clin Neurology, Elsevier Publ, Amsterdam, 50:32387., Epstein,M.H.&Johanson,C.E., 1987